TPO and autoimmune thrombocytopenic purpura: Since stimulation of megakaryopoiesis with thrombopoietin mimetics leads to a platelet increase, three second-generation TPO-RAs (romiplostim, eltrombopag, avatrombopag) have been licensed for primary ITP.